# Agentic AI Poses New Risk in Life Sciences Through Action-Taking Capabilities
Researchers highlight concerns that agentic AI systems in life sciences present a distinct risk beyond generating incorrect information—the ability to autonomously execute actions based on flawed outputs. The distinction between AI systems that merely provide wrong answers and those capable of taking wrong actions independently represents a significant safety consideration for the pharmaceutical and biotech industries.
